-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, GKkAng2w5Id+W5bpUrvKFox3iJhsqzn5J+Nk0hF0ZdTHNCrnFXQwONL7xNCJydWU RVeYP1tYCZHcjhYXDszoTg== 0000020388-98-000011.txt : 19980218 0000020388-98-000011.hdr.sgml : 19980218 ACCESSION NUMBER: 0000020388-98-000011 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19980217 SROS: NYSE GROUP MEMBERS: CIT GROUP INC GROUP MEMBERS: THE CIT GROUP/EQUITY INVESTMENTS, INC. GROUP MEMBERS: THE CIT GROUP/VENTURE CAPITAL, INC. GROUP MEMBERS: THE DAI-ICHI KANGYO BANK, LIMITED SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: MICRO THERAPEUTICS INC CENTRAL INDEX KEY: 0000311407 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330569235 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: SEC FILE NUMBER: 005-51975 FILM NUMBER: 98543716 BUSINESS ADDRESS: STREET 1: 1062 CALLE NEGOCIO #F CITY: SAN CLEMENTE STATE: CA ZIP: 92673 BUSINESS PHONE: 7143610616 MAIL ADDRESS: STREET 1: 1062 CALLE NEGOCIO #F CITY: SAN CLEMENTE STATE: CA ZIP: 92673 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: CIT GROUP INC CENTRAL INDEX KEY: 0000020388 STANDARD INDUSTRIAL CLASSIFICATION: SHORT-TERM BUSINESS CREDIT INSTITUTIONS [6153] IRS NUMBER: 132994534 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 1211 AVE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 10036 BUSINESS PHONE: 2125361950 MAIL ADDRESS: STREET 1: 1211 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: NY ZIP: 10036 FORMER COMPANY: FORMER CONFORMED NAME: CIT GROUP HOLDINGS INC /DE/ DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: CIT FINANCIAL CORP/OLD/ DATE OF NAME CHANGE: 19860512 SC 13G 1 SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. __)* MICRO THERAPEUTICS, INC. (Name of Issuer) Common Stock (Title of Class of Securities) 59500W100 (CUSIP Number) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act, but shall be subject to all other provisions of the Act (however, see the Notes). SCHEDULE 13G - -------------------------------------------------------------------------------- CUSIP No. 59500W100 Page 2 of 10 Pages - -------------------------------------------------------------------------------- =========== ==================================================================== 1 NAME OF REPORTING PERSONS/ I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) The CIT Group/Venture Capital, Inc. =========== ==================================================================== 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) |_| (b) |X| =========== ==================================================================== 3 SEC USE ONLY =========== ==================================================================== 4 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware - ------------------------------------- -------- ================================= 5 NUMBER OF SOLE VOTING POWER SHARES 351,392 -------- ================================= 6 REPORTING SHARED VOTING POWER BENEFICIALLY 0 -------- ================================= 7 OWNED BY SOLE DISPOSITIVE POWER EACH 351,392 -------- ================================= 8 PERSON SHARED DISPOSITIVE POWER WITH 0 =========== ==================================================================== 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 351,392 =========== ==================================================================== 10 CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES |_| (See Instructions) =========== ==================================================================== 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 5.4% =========== ==================================================================== 12 TYPE OF REPORTING PERSON (See Instructions) CO =========== ==================================================================== SCHEDULE 13G - -------------------------------------------------------------------------------- CUSIP No. 59500W100 Page 3 of 10 Pages - -------------------------------------------------------------------------------- =========== ==================================================================== 1 NAME OF REPORTING PERSONS/ I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) The CIT Group/Equity Investments, Inc. =========== ==================================================================== 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) |_| (b) |X| =========== ==================================================================== 3 SEC USE ONLY =========== ==================================================================== 4 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware - ------------------------------------- -------- ================================= 5 NUMBER OF SOLE VOTING POWER SHARES 0 -------- ================================= 6 REPORTING SHARED VOTING POWER BENEFICIALLY 351,392 -------- ================================= 7 OWNED BY SOLE DISPOSITIVE POWER EACH 0 -------- ================================= 8 PERSON SHARED DISPOSITIVE POWER WITH 351,392 =========== ==================================================================== 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 351,392 =========== ==================================================================== 10 CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES |_| (See Instructions) =========== ==================================================================== 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 5.4% =========== ==================================================================== 12 TYPE OF REPORTING PERSON (See Instructions) CO =========== ==================================================================== SCHEDULE 13G - -------------------------------------------------------------------------------- CUSIP No. 59500W100 Page 4 of 10 Pages - -------------------------------------------------------------------------------- =========== ==================================================================== 1 NAME OF REPORTING PERSONS/ I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) The CIT Group, Inc. =========== ==================================================================== 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) |_| (b) |X| =========== ==================================================================== 3 SEC USE ONLY =========== ==================================================================== 4 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware - ------------------------------------- -------- ================================= 5 NUMBER OF SOLE VOTING POWER SHARES 0 -------- ================================= 6 REPORTING SHARED VOTING POWER BENEFICIALLY 351,392 -------- ================================= 7 OWNED BY SOLE DISPOSITIVE POWER EACH 0 -------- ================================= 8 PERSON SHARED DISPOSITIVE POWER WITH 351,392 =========== ==================================================================== 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 351,392 =========== ==================================================================== 10 CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES |_| (See Instructions) =========== ==================================================================== 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 5.4% =========== ==================================================================== 12 TYPE OF REPORTING PERSON (See Instructions) CO =========== ==================================================================== SCHEDULE 13G - -------------------------------------------------------------------------------- CUSIP No. 59500W100 Page 5 of 10 Pages - -------------------------------------------------------------------------------- =========== ==================================================================== 1 NAME OF REPORTING PERSONS/ I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) The Dai-Ichi Kangyo Bank, Ltd. =========== ==================================================================== 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) |_| (b) |X| =========== ==================================================================== 3 SEC USE ONLY =========== ==================================================================== 4 CITIZENSHIP OR PLACE OF ORGANIZATION Japan - ------------------------------------- -------- ================================= 5 NUMBER OF SOLE VOTING POWER SHARES 0 -------- ================================= 6 REPORTING SHARED VOTING POWER BENEFICIALLY 351,392 -------- ================================= 7 OWNED BY SOLE DISPOSITIVE POWER EACH 0 -------- ================================= 8 PERSON SHARED DISPOSITIVE POWER WITH 351,392 =========== ==================================================================== 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 351,392 =========== ==================================================================== 10 CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES |_| (See Instructions) =========== ==================================================================== 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 5.4% =========== ==================================================================== 12 TYPE OF REPORTING PERSON (See Instructions) BK =========== ==================================================================== Item 1. (a) Name of Issuer: Micro Therapeutics, Inc. (b) Address of Issuer's Principal Executive Offices: 1062 Calle Negocio #F San Clemente, California 92673 Item 2. (a) Name of Person Filing: Pursuant to Rule 13d-1(f)(1) of Regulation 13D-G as promulgated under the Securities Exchange Act of 1934, as amended (the "1934 Act"), the undersigned hereby file this Schedule 13G on behalf of The CIT Group/Venture Capital, Inc. ("CIT Venture"), The CIT Group/Equity Investments, Inc. ("CIT Equity"), The CIT Group, Inc. ("CIT Group") and The Dai-Ichi Kangyo Bank, Ltd. ("Dai-Ichi"). CIT Venture, CIT Equity, CIT Group and Dai-Ichi are referred to herein as the "Reporting Persons". As of December 31, 1997, CIT Venture owned 351,392 shares of Common Stock of Micro Therapeutics, Inc. (the "Company"). All of the outstanding shares of CIT Venture are owned by CIT Equity, the beneficial owner of which is CIT Group. Approximately 80% of the outstanding capital stock of CIT Group is owned by Dai-Ichi. As a result, CIT Equity, CIT Group and Dai-Ichi may be deemed to have shared power to vote and dispose of the shares of Common Stock of the Company directly owned by CIT Venture. Pursuant to Rule 13d-4 of Regulation 13D-G as promulgated under the 1934 Act, each Reporting Person disclaims beneficial ownership of the Common Stock of the Company held by CIT Venture, except to the extent of their pecuniary interest therein, and the filing of this Schedule 13G by the Reporting Persons shall not be deemed an admission that such Reporting Persons are, for the purposes of Section 13(d) or 13(g) of the 1934 Act, beneficial owners of such Common Stock. (b) Address of Principal Business Office: The principal business address for each of CIT Venture, CIT Equity and CIT Group is 650 CIT Drive, Livingston, New Jersey 07039-5795. The principal business address for Dai-Ichi is: 1-5, Uchisaiwaicho 1-chome, Chiyada-ku, Tokyo 100 Japan. (c) Citizenship: CIT Venture, CIT Equity and CIT Group are organized in the State of Delaware. Dai-Ichi is organized under the laws of Japan. (d) Title of Class of Securities: Common Stock (e) CUSIP Number: 59500W100 Item 3. If this statement is filed pursuant Rule 13d-1(b), or 13d-2(b), check whether the person filing is a: (a) |_| Broker or dealer registered under Section 15 of the Act; (b) |_| Bank as defined in Section 3(a)(6) of the Act; (c) |_| Insurance Company as defined in Section 3(a)(19) of the Act; (d) |_| Investment Company registered under Section 8 of the Investment Company Act; (e) |_| Investment Advisor registered under Section 203 of the Investment Advisors Act of 1940; (f) |_| Employee Benefit Plan, Pension Fund which is subject to the provisions of the Employee Retirement Income Security Act of 1974 or Endowment Fund; see Rule 13d-1(b)(1)(ii)(F) (g) |_| Parent Holding Company, in accordance with Rule 13d-1(b)(ii)(G) (Note, See Item 7); (h) |_| Group, in accordance with Rule 13d-1(b)(1)(ii)(H). Item 4. Ownership. If the percent of the class owned, as of December 31, 1997, or as of the last day of any month described in Rule 13d-1(b)(2), if applicable, exceeds five percent, provide the following information as of that date and identify those shares which there is a right to acquire. With respect to CIT Venture: (a) Amount beneficially owned: 351,392 shares of Common Stock (b) Percent of Class: 5.4% (c) Number of shares as to such person has: (i) sole power to vote or to direct the vote of 351,392; (ii) shared power to vote or to direct the vote of 0; (iii) sole power to dispose or to direct the disposition of 351,392; (iv) shared power to dispose or to direct the disposition of 0. With respect to CIT Equity, CIT Group and Dai-Ichi: (a) Amount beneficially owned: 351,392 shares of Common Stock (b) Percent of class: 5.4% (c) Number of shares as to such person has: (i) sole power to vote or to direct the vote of 0; (ii) shared power to vote or to direct the vote of 351,392; (iii) sole power to dispose or to direct the disposition of 0; (iv) shared power to dispose or to direct the disposition of 351,392. Item 5. Ownership of 5% or Less of Class. If this statement is being filed to report the fact that as of the date hereof the reported person has ceased to be the beneficial owner of more than 5% of the class of securities, check the following: |_| Item 6. Ownership of More Than 5% on Behalf of Another Person Not applicable. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company. Not applicable. Item 8. Identification and Classification of Members of the Group. Not applicable. Item 9. Notice of Dissolution of Group. Not applicable. Item 10. Certification. Not applicable. Exhibit A. Joint Filing Agreement pursuant to Rule 13d-1(f)(1)(iii) SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. The CIT Group/Venture Capital, Inc. Date: February 12, 1998 By: Paul J. Laud ------------ Its: President The CIT Group/Equity Investments, Inc. Date: February 12, 1998 By: Paul J. Laud ------------ Its: President The CIT Group, Inc. Date: February 12, 1998 By: Joseph M. Leone --------------- Its: Chief Financial Officer The Dai-Ichi Kangyo Bank, Ltd. Date: February 12, 1998 By: Naoto Takano ------------ Its: Assistant General Manager IPCD of The Dai-Ichi Kangyo Bank, Limited EXHIBIT A Joint Filing Agreement Pursuant to Rule 13d-1(f)(1)(iii)of Regulation 13D-G as promulgated under the Securities Exchange Act of 1934, as amended, the undersigned agree to the joint filing of a Schedule 13G with respect to the shares of Common Stock of Micro Therapeutics, Inc. and that the Schedule 13G to which this Joint Filing Agreement is attached is filed on behalf of each of them. In addition, each party to this Joint Filing Agreement expressly authorizes each other party to this Joint Filing Agreement to file on its or his behalf any and all amendments to such Schedule 13G. The CIT Group/Venture Capital, Inc. Date: February 12, 1998 By: Paul J. Laud ------------ Its: President The CIT Group/Equity Investments, Inc. Date: February 12, 1998 By: Paul J. Laud ------------ Its: President The CIT Group, Inc. Date: February 12, 1998 By: Joseph M. Leone --------------- Its: Chief Financial Officer The Dai-Ichi Kangyo Bank, Ltd. Date: February 12, 1998 By: Naoto Takano ------------ Its: Assistant General Manager IPCD of The Dai-Ichi Kangyo Bank, Limited -----END PRIVACY-ENHANCED MESSAGE-----